Ads
related to: drugs, lung cancer- Patient & Caregiver Info
Download Patient Brochures & Get
Additional Support For Caregivers
- Dosing Information
Review Dosing & Administration
Recommendations For Your Patients
- Resources For Physicians
View & Download Important Resources
Testing Info, Access Kits & More
- Learn About KRAS G12C
Find Testing Info & Get Resources
For HCPs, Patients & Caregivers
- Review Safety Information
Learn More About Important Safety
Info On The Official Physician Site
- Connect With A Rep
HCPs & Physicians Register Today To
Be Connected With A Representative
- Patient & Caregiver Info
Search results
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 6 days agoAlso Read: Pfizer Agrees To Settle Over 10,000... Cancer Risks Associated With Discontinued...
New pathways for treating never-smoker lung cancer revealed
Medical Xpress· 3 days agoThe primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.
Cancer patients often do better with less intensive treatment, research shows
NBC NEWS· 3 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Lack of insurance may prevent Americans from accessing best cancer drugs
UPI· 3 days agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 6 days agoTrodelvy has accelerated U.S. approval for treating advanced urothelial cancer, but Gilead on...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 2 days agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 7 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc ...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WSAU Wausau· 6 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
Ads
related to: drugs, lung cancer